同大類學(xué)科其它級(jí)別期刊:
中科院 1區(qū) 期刊 JCR Q1 期刊 中科院 2區(qū) 期刊 JCR Q2 期刊 中科院 3區(qū) 期刊 JCR Q3 期刊 中科院 4區(qū) 期刊 JCR Q4 期刊國(guó)際簡(jiǎn)稱:International Journal Of Particle Therapy 參考譯名:國(guó)際粒子治療雜志
主要研究方向:Medicine-Radiology, Nuclear Medicine and Imaging 非預(yù)警期刊 審稿周期: 20 Weeks
《國(guó)際粒子治療雜志》(International Journal Of Particle Therapy)是一本由Allen Press出版的以Medicine-Radiology, Nuclear Medicine and Imaging為研究特色的國(guó)際期刊,發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章,及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn),旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊,近三年沒有被列入預(yù)警名單。
The International Journal of Particle Therapy (IJPT) is an internationally peer-reviewed journal focused on the field of particle therapy, published by Allen Press. Particle therapy is an advanced cancer treatment technique that includes proton therapy, heavy ion therapy, and others. The ISSN of this journal is 2331-5180, mainly publishing basic research, clinical research, technological development, dosimetry, biological effects, advances in physics, and innovative research on related equipment and methods related to particle therapy. The author does not retain unlimited copyright and publishing rights after publishing the article. The article is digitally archived in CLOCKSS, PMC, and Portico, with DOI as the permanent article identifier.
CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||||||
3.7 | 0.762 | 0.83 |
|
名詞解釋:CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù),是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年(含計(jì)算年度)的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如,2022年的 CiteScore 計(jì)算方法為:2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量 注:文獻(xiàn)類型包括:文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。
按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:ONCOLOGY | ESCI | Q3 | 214 / 322 |
33.7% |
學(xué)科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ESCI | Q2 | 96 / 204 |
53.2% |
按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:ONCOLOGY | ESCI | Q3 | 231 / 322 |
28.42% |
學(xué)科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ESCI | Q3 | 136 / 204 |
33.58% |